RiverVest Venture Partners focuses exclusively on innovations in life sciences, providing practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward.

RiverVest founds and actively incubates life science companies, through its Archer Seed Fund, and also invests in select later-stage opportunities to diversify risk and maximize portfolio returns. The firm takes a hands-on approach to investment, preferring to be represented on the boards of their portfolio companies.

For more information, visit RiverVest Venture Partners or follow their updates on:

RiverVest Closes Raise of $184.4 Million on Fourth Life Sciences Fund

Securus Medical Group Sold to Boston Scientific Corporation for $50 Million

Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

Adarza BioSystems

Adarza BioSystems Closes on $17 Million – What’s Next for the Life Science Startup

Karen Gheesling Mullis

RiverVest Closes $15 Million Biopharma Pre-Seed Fund, Says It Will Focus on Midwest Companies

SixThirty And Stadia Announce New Cohort Companies

STL Startup Funding

STL Startup Funding Guide

Jay Schmelter

Capital Ideas: Jay Schmelter of RiverVest

2015 St. Louis Capital Report: Brian Matthews Outlines Funding From Angels and Venture Capitalists